There is 1 version of this bill. View text

Click the check-box to add or remove the section, click the text link to scroll to that section.
Titles Actions Overview All Actions Cosponsors Committees Related Bills Subjects Latest Summary All Summaries

Titles (2)

Short Titles

Short Titles - Senate

Short Titles as Introduced

End Taxpayer Subsidies for Drug Ads Act

Official Titles

Official Titles - Senate

Official Titles as Introduced

A bill to amend the Internal Revenue Code of 1986 to deny the deduction for advertising and promotional expenses for prescription drugs.


Actions Overview (1)

Date Actions Overview
03/01/2018Introduced in Senate

All Actions (1)

Date All Actions
03/01/2018Read twice and referred to the Committee on Finance.
Action By: Senate

Cosponsors (3)

* = Original cosponsor
CosponsorDate Cosponsored
Sen. Shaheen, Jeanne [D-NH]* 03/01/2018
Sen. Brown, Sherrod [D-OH] 03/05/2018
Sen. King, Angus S., Jr. [I-ME] 07/25/2018

Committees (1)

Committees, subcommittees and links to reports associated with this bill are listed here, as well as the nature and date of committee activity and Congressional report number.

Committee / Subcommittee Date Activity Reports
Senate Finance03/01/2018 Referred to

A related bill may be a companion measure, an identical bill, a procedurally-related measure, or one with text similarities. Bill relationships are identified by the House, the Senate, or CRS, and refer only to same-congress measures.


Subjects (5)


Latest Summary (1)

There is one summary for S.2478. View summaries

Shown Here:
Introduced in Senate (03/01/2018)

End Taxpayer Subsidies for Drug Ads Act

This bill amends the Internal Revenue Code to prohibit tax deductions for expenses relating to direct-to-consumer advertising of prescription drugs.

"Direct-to-consumer advertising" is any dissemination, by or on behalf of a sponsor of a prescription drug product, of an advertisement that is: (1) in regard to the drug product, and (2) primarily targeted to the general public.